The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Faced with the explosive outbreak of COVID-19 across the globe, the biopharmaceutical industry is working with academic institutions and health authorities to develop new therapeutic products and preventive medicines. In this half-day virtual discussion forum, we will look at several ongoing studies on the strategies and progress of product and process development- all within accelerated timeline. Researchers and regulators have taken on this unprecedented challenge with innovative technologies, acceleration and risk-based control strategies. With the sharing of demonstrated ability to shorten development timelines required to bring forward treatment options desperately needed to save lives in this pandemic, we aspire to identify new ideas, effective strategies, and efficient CMC (Chemistry, Manufacturing and Control) practices that can lead to faster development of many other important medicines.